41,341 Results

The European commission approves expanded use of Janssen’s Stelara® (ustekinumab) for the treatment of paediatric patients with moderate to severe plaque psoriasis

 Added 1 day ago

The European commission approves expanded use of Janssen’s Stelara® (ustekinumab) for the treatment of paediatric patients with moderate to severe plaque psoriasis.

Janssen responds to the national institute for health and care excellence (nice) draft guidance for STELARA® (ustekinumab) in ulcerative colitis

 Added 1 day ago

Janssen responds to the national institute for health and care excellence (nice) draft guidance for STELARA® (ustekinumab) in ulcerative colitis

Ipsen to pause dosing patients in the global Phase III (PVO-1A-301) study to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva.

 Added 1 day ago

Ipsen announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy...

NICE does not recommend Saxenda as a treatment for obesity. - Novo Nordisk

 Added 1 day ago

The National Institute for Health and Care Excellence (NICE) has rejected Saxenda ( liraglutide) from Novo Nordisk for use on...

FDA accepts refiling of intravenous (IV) meloxicam for the management of moderate to severe pain.- Baudax Bio

 Added 1 day ago

Baudax Bio, Inc. a specialty pharmaceutical company focused on therapeutics for acute care settings, announced that the FDA has set...

New indication approved for Infinity Deep Brain Stimulation (DBS) system to improve symptoms of Parkinson's disease.- Abbott

 Added 3 days ago

Abbott has announced it received approval from the FDA for a new, expanded indication for the company's Infinity Deep Brain...

Phase III AKP01 study of Akvano shows efficacy in plaque psoriasis.- Lipidor

 Added 3 days ago

Lipidor AB reports positive topline results of its AKP01 Phase III clinical study, using Akvano (calcipotriol spray) against mild to...

Tecentriq fails in Phase III IMvigor010 study as an adjuvant (after surgery) monotherapy compared to observation in people with muscle-invasive urothelial cancer .-Genentech/Roche

 Added 3 days ago

Roche announced that the Phase III IMvigor010 study evaluating Tecentriq (atezolizumab) as an adjuvant (after surgery) monotherapy treatment did not...

FDA grants accelerated approval for Tazervik to treat metastatic or locally advanced epithelioid sarcoma .- Epizyme Inc.

 Added 3 days ago

-Epizyme, Inc. announced that the FDA has granted accelerated approval of Tazverik (tazemetostat) for the treatment of adults and pediatric...

Additional indications in Japan for Fycompa for partial-onset seizures. Eisai

 Added 4 days ago

Eisai Co., Ltd.announced that it has obtained the approvals of supplementary new drug applications in Japan for its in-house developed...

Load more